167 related articles for article (PubMed ID: 1314113)
81. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
82. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
83. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
84. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage.
Shimodaira S; Ishida F; Kobayashi H; Mahbub B; Kawa-Ha K; Kitano K
Br J Haematol; 1995 Jul; 90(3):578-84. PubMed ID: 7646997
[TBL] [Abstract][Full Text] [Related]
85. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
Fåhraeus R; Fu HL; Ernberg I; Finke J; Rowe M; Klein G; Falk K; Nilsson E; Yadav M; Busson P
Int J Cancer; 1988 Sep; 42(3):329-38. PubMed ID: 2843473
[TBL] [Abstract][Full Text] [Related]
86. Quantitation of Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA) by a two-site enzyme immunoassay, in parallel with EBV-DNA.
Sternås L; Eliasson L; Lerner R; Klein G
J Immunol Methods; 1986 May; 89(2):151-8. PubMed ID: 3009623
[TBL] [Abstract][Full Text] [Related]
87. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
88. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis.
Kwong YL; Lam CC; Chan TM
Br J Haematol; 2000 Jul; 110(1):197-202. PubMed ID: 10930998
[TBL] [Abstract][Full Text] [Related]
89. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
[TBL] [Abstract][Full Text] [Related]
90. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
91. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
92. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
93. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
[TBL] [Abstract][Full Text] [Related]
94. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
95. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
96. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
97. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
98. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
[TBL] [Abstract][Full Text] [Related]
99. Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma.
Kanegane H; Wang F; Tosato G
Blood; 1996 Dec; 88(12):4667-75. PubMed ID: 8977260
[TBL] [Abstract][Full Text] [Related]
100. Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis.
Oshimi K; Oshimi Y; Akahoshi M; Kobayashi Y; Hirai H; Takaku F; Hattori M; Asano S; Kodo H; Nishinarita S
Blood; 1988 Feb; 71(2):473-9. PubMed ID: 2447984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
